These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32725139)

  • 1. cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis.
    Worrell JC; Leslie J; Smith GR; Zaki MYW; Paish HL; Knox A; James ML; Cartwright TN; O'Reilly S; Kania G; Distler O; Distler JHW; Herrick AL; Jeziorska M; Borthwick LA; Fisher AJ; Mann J; Mann DA; Oakley F
    Rheumatology (Oxford); 2020 Dec; 59(12):3939-3951. PubMed ID: 32725139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
    Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
    Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis.
    Egal ESA; Kamdem SD; Yoshigi M; Yang CC; Pellizzari S; Kameni EM; Helms MN; Assassi S; Henkemeyer M; Frech TM; Mimche PN
    Arthritis Rheumatol; 2024 Aug; 76(8):1303-1316. PubMed ID: 38589317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
    Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
    Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-Rel subunit of NF-κB regulates epidermal homeostasis and promotes skin fibrosis in mice.
    Fullard N; Moles A; O'Reilly S; van Laar JM; Faini D; Diboll J; Reynolds NJ; Mann DA; Reichelt J; Oakley F
    Am J Pathol; 2013 Jun; 182(6):2109-20. PubMed ID: 23562440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs.
    Cao L; Lafyatis R; Burkly LC
    PLoS One; 2017; 12(6):e0180751. PubMed ID: 28662216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.
    Palumbo-Zerr K; Soare A; Zerr P; Liebl A; Mancuso R; Tomcik M; Sumova B; Dees C; Chen CW; Wohlfahrt T; Mallano T; Distler A; Ramming A; Gelse K; Mihai C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2017 Jan; 76(1):244-251. PubMed ID: 27113414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
    Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
    PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.
    Tomcik M; Palumbo-Zerr K; Zerr P; Avouac J; Dees C; Sumova B; Distler A; Beyer C; Cerezo LA; Becvar R; Distler O; Grigorian M; Schett G; Senolt L; Distler JH
    Ann Rheum Dis; 2015 Sep; 74(9):1748-55. PubMed ID: 24709861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.